- Easy Tracking In The Watchlist
Anavex Life Sciences Corp. stock upgraded from Strong Sell Candidate to Sell Candidate after Thursday trading session
(Updated on Jun 11, 2026)
The Anavex Life Sciences Corp. stock price gained 1.63% on the last trading day (Thursday, 11th Jun 2026), rising from $2.46 to $2.50. During the last trading day the stock fluctuated 5.19% from a day low at $2.41 to a day high of $2.54. The price has fallen in 6 of the last 10 days and is down by -14.97% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 46 thousand more shares were traded than the day before. In total, 957 thousand shares were bought and sold for approximately $2.39 million.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.44 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -28.45% during the next 3 months and, with a 90% probability hold a price between $1.74 and $2.43 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
AVXL Signals & Forecast
There are mixed signals in the stock today. The Anavex Life Sciences Corp. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.59 and $2.97. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 1.63%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.
Support, Risk & Stop-loss for Anavex Life Sciences Corp. stock
Anavex Life Sciences Corp. finds support from accumulated volume at $2.46 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.125 between high and low, or 5.19%. For the last week, the stock has had daily average volatility of 6.93%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (AVXL) For The Upcoming Trading Day Of Friday 12th
For the upcoming trading day on Friday, 12th we expect Anavex Life Sciences Corp. to open at $2.48, and during the day (based on 14 day Average True Range), to move between $2.41 and $2.59, which gives a possible trading interval of +/-$0.187 (+/-7.78%) up or down from last closing price. If Anavex Life Sciences Corp. takes out the full calculated possible swing range there will be an estimated 7.78% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $2.46 (1.60%) than the resistance at $2.74 (9.60%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Anavex Life Sciences Corp. will release earnings BMO on Tuesday, June 16, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.0700. We will update the financials statements for Anavex Life Sciences Corp., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 13.07% in the first trading day after earnings release.
Is Anavex Life Sciences Corp. stock A Buy?
Anavex Life Sciences Corp. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.
Current score:
-2.525
Sell Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 12, 2026 - $2.48 ( 0.733%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
AVXL Performance
Trading levels for AVXL
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.61 | 4.27% |
| R2 | 2.56 | 2.36% |
| R1 | 2.53 | 1.18% |
| Price | 2.50 | |
| S1 | 2.43 | -2.64% |
| S2 | 2.40 | -3.82% |
| S3 | 2.36 | -5.73% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.88 | 15.20% |
| R2 | 2.82 | 12.80% |
| R1 | 2.74 | 9.60% |
| Price | 2.50 | |
| S1 | 2.46 | -1.60% |
| S2 | 0 | - |
| S3 | 0 | - |
FAQ
Click here for our free guide on how to buy Anavex Life Sciences Corp. Stock.
Buy AVXL